John Lubniewski
Chief Executive Officer at HTG MOLECULAR DIAGNOSTICS, INC.
Net worth: 2 $ as of 2024-03-30
Profile
John L.
Lubniewski is currently the President, Chief Executive Officer & Director at HTG Molecular Diagnostics, Inc. He previously worked as the Director of New Business Development at Corning, Inc. and as the Senior Vice President at Ventana Medical Systems, Inc. from 2010 to 2011.
He also held the position of Principal at Hoffmann-La Roche, Inc. Mr. Lubniewski completed his undergraduate degree at Clarkson University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-28 | 1,177 ( 0.05% ) | 2 $ | 2024-03-30 |
John Lubniewski active positions
| Companies | Position | Start |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Chief Executive Officer | 2019-03-30 |
Former positions of John Lubniewski
| Companies | Position | End |
|---|---|---|
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | 2011-03-31 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| CORNING INCORPORATED | Corporate Officer/Principal | - |
Training of John Lubniewski
| Clarkson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CORNING INCORPORATED | Electronic Technology |
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| Private companies | 2 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- John Lubniewski
